packageFoslevodopaAndDecarboxylaseInhibitor

foslevodopa and decarboxylase inhibitor

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Foslevodopa (combined with a decarboxylase inhibitor) is an anti-Parkinson drug belonging to the dopa derivatives, used to treat Parkinson's disease. It is an approved medicine, though detailed information on where and how widely it is used is not available here.

Summary written by glm-5.3-flash from Wikidata Q82874569 and the WHO ATC classification; not checked by a person.

name:foslevodopa and decarboxylase inhibitor
ATC codes:N04BA07
DrugBank:DB16683
ChEBI:192509
Wikidata:Q82874569
formula:C9H12NO7P
molar mass:277.169 g/mol (knowledgebase (DrugBank calculated))
logP:-1.3 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown